Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Milestone Pharmaceuticals Inc.MIST · Entity 6561 | Chief Medical Officer | March 24, 2021 | March 27, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Milestone Pharmaceuticals Inc.
Report date March 24, 2021 · Filed March 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.26 · Expires 2031-03-24 | Direct | 130,000 |
Reported balance
After 2021-03-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-24 · Grant · Acquired 130,000 · Balance 130,000 F1: One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2021 Filed Mar 27, 2021 00:40 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | GrantEmployee Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $6.26 | $0.00 |
DisclosureSEC source: 0001209191-21-023352 · doc4.xml · derivative · entry 1 Plat Francis · CIK 0001772290 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Shares · 130,000 shares Expires 2031-03-24 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 23:30 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | GrantEmployee Stock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001209191-20-035129 · doc4.xml · derivative · entry 1 Plat Francis · CIK 0001772290 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Shares · 35,000 shares Expires 2030-06-05 F1 · derivative.exercise_date: The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 22:39 UTC | Milestone Pharmaceuticals Inc. MIST · Entity 6561 | GrantEmployee Stock Option (right to buy) · Derivative | 84,000 | $0.00 Strike: $21.48 | $0.00 |
DisclosureSEC source: 0001209191-20-004903 · doc4.xml · derivative · entry 1 Plat Francis · CIK 0001772290 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Shares · 84,000 shares Expires 2030-01-23 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vest on January 23, 2021 and one forty-eighth (1/48th) of the shares subject to the option vest on each one month anniversary thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.